Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.40 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6948771 | 0.92 | MAPT (0.43) | MAPTHSD17B10KDM4ELMNAALDH1A1 | |
| SCHEMBL7653164 | 0.92 | ALDH1A1 (0.42) | MAPTHSD17B10NPC1RAB9AKDM4E | |
| SCHEMBL6950396 | 0.91 | MAPT (0.48) | MAPTHSD17B10NPC1RAB9AKDM4E | |
| SCHEMBL7650918 | 0.90 | NPC1 (0.40) | MAPTNPC1RAB9AKDM4ELMNA | |
| Hydrochloric Acid SCHEMBL6953896 | 0.90 | MAPT (0.47) | MAPTHSD17B10NPC1RAB9AKDM4E | |
| SCHEMBL6953839 | 0.90 | POLB (0.42) | MAPTHSD17B10NPC1RAB9AALDH1A1 | |
| SCHEMBL6952449 | 0.89 | MMP2 (0.45) | MAPTHSD17B10NPC1RAB9AKDM4E | |
| SCHEMBL7656015 | 0.88 | ALDH1A1 (0.42) | MAPTHSD17B10NPC1RAB9AKDM4E | |
| SCHEMBL7657259 | 0.87 | NPC1 (0.39) | MAPTHSD17B10NPC1RAB9AKDM4E | |
| SCHEMBL7649497 | 0.87 | NPC1 (0.41) | MAPTNPC1RAB9ANTRK1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210060158-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2021-03-04 | — | — | US | claimed |
| EP-3684410-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | Institut Curie (FR) | 2020-07-29 | — | — | EP | claimed |
| WO-2019057744-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | INSTITUT CURIE (FR) | 2019-03-28 | — | — | WO | claimed |
| US-20230152314-A1 | LIPOCALIN-2 ASSAY FOR INTESTINAL ADAPTATION | THE JOHNS HOPKINS UNIVERSITY | 2023-05-18 | — | — | US | disclosed |
| US-20210060158-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2021-03-04 | — | — | US | disclosed |
| EP-3684410-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | Institut Curie (FR) | 2020-07-29 | — | — | EP | disclosed |
| WO-2019057744-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | INSTITUT CURIE (FR) | 2019-03-28 | — | — | WO | disclosed |
| EP-0936218-B1 | BENZIMIDAZOLE DERIVATIVES | MOCHIDA PHARM CO LTD (JP) | 2003-04-02 | — | — | EP | disclosed |
| US-6387938-B1 | Benzimidazole derivatives | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-14 | — | — | US | disclosed |
| EP-0936218-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1999-08-18 | — | — | EP | disclosed |